MedDataX Logo

Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

NCT ID: NCT00173316

Last Updated: 2005-09-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-08-31

Study Completion Date

2005-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oral Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

vascular endothelial growth factor-C VEGF-CR lymphangiogenesis host inflammatory responses oral carcinogenesis oral cancers oral premalignant lesions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* oral cancer and oral precancer specimens

Exclusion Criteria

* other diseases
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chun-Pin Chiang, DMSc

Role: PRINCIPAL_INVESTIGATOR

National Taiwan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan university

Taipei, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chun-Pin Chiang, DMSc

Role: CONTACT

Phone: 886-2-23123456

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9461700614

Identifier Type: -

Identifier Source: org_study_id